Overall Survival in Patients with Endometrial Cancer Treated with Dostarlimab plus Carboplatin-Paclitaxel in the Randomized ENGOT-EN6/GOG-3031/RUBY Trial

GSK authors: M. Marco Balas; Ma. Grimshaw; S. Stevens; D.W. Lai